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This study examined the effects of long-term 
lithium therapy on memory functions in 18 pa-
tients suffering from bipolar affective disorder. 
Patients were retested on the Wechsler Memory 
Scale, Benton Visual Retention Test, and Zung 
Self-Rating Depression Scale 6 years after initial 
testing. Mean memory test scores remained re-
markably stable over the 6-year interval with only 
one of the 10 memory subtests showing a statis-
tically, but not clinically, significant decrease. The 
sample was split at the median duration of lithium 
therapy into a long- and shorter term group (with 
means of 12.9 and 5.2 years, respectively). There 
were no significant differences between these 
groups on any of the memory tests when controlled 
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for age and initial memory scores. Negative cor-
relations between several memory test scores and 
the duration of lithium treatment could in part be 
explained by the effects of age. Patients' subjective 
complaints of impaired memory functioning, rated 
on a visual analogue scale, correlated with the 
level of depression at the second testing as well as 
with three memory test scores measuring immedi-
ate and short-term visual recall. The results are 
discussed in view of the demographic and clinical 
characteristics of the sample and are compared 
with previous research findings. 
(J Clin Psychopharmacol1988;8:207-212) 
T HE INCREASING use of lithium carbonate as the treatment of choice for bipolar affective disorder 
has highlighted a major concern for patients and clini-
cians alike, calling for controlled studies of the long-
term effects of lithium therapy on cognitive and memory 
functioning. Excluding detailed reports of the deleteri-
ous effects of acute lithium toxicity,I-:1 which recently 
have been reviewed elsewhere,4 several studies have 
found impaired cognitive and memory functioning in 
patients receiving lithium therapy.s.-11 In particular, the 
study by Reus and colleagues7 demonstrated that pa-
tients treated with lithium were unable to recall as 
many items on a verbal learning task as a control group 
of patients not receiving lithium. Nair and associates11 
found correlations between the duration of lithium 
therapy, severity of EEG abnormalities, and reduced 
WAIS Performance IQ scores. Episodic slow wave ac-
tivity in the EEG was associated with mental slowing in 
the toxicity rating scale. A more recent study by Lund 
and coworkers6 found that patients maintained on long-
term lithium therapy scored significantly lower on a 
test of immediate recall of digits than those receiving 
lithium for a shorter duration, although the difference 
in mean number of digits recalled was exceedingly 
small. 
In contrast to these findings, a number of controlled 
and uncontrolled studies have failed to demonstrate 
such "lithium-induced" deficits. Ghadirian and col-
leagues!l compared patients receiving long-term lith-
ium therapy with a short-term lithium treatment group 
and did not find any evidence of memory impairment 
when the patients were tested on well recognized and 
widely used tests of memory functioning. Other recent 
studies have reported similar results. 111• 11 
Taken together, the results of studies that have exam-
ined the effects oflithium on memory functioning in pa-
tients are equivocal; some show impaired performance 
on memory tests, while others find little or no deficits 
resulting from lithium treatment. The reasons for this 
lack of empirical consensus are numerous and in part 
arise from the heterogeneity of patient samples ad-
mitted into studies, differences in the classification 
schemes used in diagnosis, varying durations of lithium 
treatment, conceptual differences in the definitions of 
short-term and long-term memory, and a variety of 
methodological and design problems. 
The aim of the present study was to follow-up and re-
test the patients who participated in a previous study of 
memory and lithium therapy approximately 6 years 
agoY The results of that study demonstrated that the 
duration of lithium therapy in 30 patients with bipolar 
affective illness was not found to adversely affect mem-
ory functioning when such variables as serum lithium, 
psychopathology, age, and physical illness were taken 
into consideration. ln the present study, patients were 
retested on the Wechsler Memory Scale, the Benton Vi-
sual Retention Test. and the Zung Self-Rating Depres-
sion Scale under the hypothesis that long-term lithium 
therapy would not lead to impaired memory function-
ing. More specifically, based on the previous findings, 
we tested the hypothesis that memory test scores from 
the first and second testings would not differ signifi-
cantly. A second corollary hypothesis predicted that the 
patients' subjective ratings of their sense of memory im-
pairment would correlate significantly with their level 
of depression but not with the objective memory test 
findings. 
Subjects and Methods 
Subjects 
Eighteen of the 30 patients who participated in the 
earlier study were retested. The remainder were either 
unwilling to participate or could not be reached. The 
present sample consisted of 12 men and six women rang-
ing in age from 28 to 67 years, with a mean age of 45.8. 
All patients were treated at the Allan Memorial In-
stitute Affective Disorders Clinic and were included in 
the study with their consent. The diagnosis of affective 
disorder was made on the basis of clinical assessment 
and personal and family history and according to DSM-
IIII• criteria. The criteria for exclusion were acute phys-
ical illness, organic brain syndrome, perceptual disor-
ders, acute psychopathology, electroconvulsive therapy 
during the past 3 months, and large dosages of concomi-
tant psychotropic medication. At the second testing, one 
patient was on a modest dosage of antidepressant medi-
cation and two were receiving small dosages of anxioly-
tic medication. 
Test battery 
The following tests were readministered to the 
patients. 
Wechsler Memory Scale (WMSJ. This test is widely 
used with clinical populations to measure short-term 
and long-term memory functions and yields a memory 
quotient (corrected for agel and scores in the following 
subtests: information, orientation, mental control, logi-
cal memory, digit span, visual reproduction , and asso-
ciate learning. 
Benton Visual Retention Test fBVRTJ. This is a per-
formance test consisting of 10 cards with geometric de-
signs graded in difficulty ranging from one single fig-
ure to three complex figures on a card. The test requires 
spatial perception, immediate recall, and visual-motor 
skills to reproduce the drawing after 10 seconds of ex-
posure and a 15-second delay (form Dl. Scoring consists 
of the number of cards correctly reproduced (0 to 10) and 
the number of errors within each reproduction (ranging 
from a total of 0 to 26). The test retest reliability of the 
BVRT is quite high. Coefficients of concordance be-
tween the BVRT scores at two testings 1 year apart were 
0.74 for the number of correct designs and 0.77 for the 
number of errors.l3 
Zung Self-Rating Depression Scale (SDSJ. This scale 
consists of20 items yielding a total raw score and an in-
dex (raw score multiplied by a coefficient ofl.25 for nor-
malization purposes). The Zung SDS is widely used in 
clinical studies of depressed psychiatric patients with 
satisfactory reliability for a self-report instrument. 14 
An SDS index of 60 indicates the presence of moderate 
to marked depression and serves as a cutoff point in 
clinical and research studies. 
Structured Interuiew Schedule (SIS). This schedule 
aided in gathering the following data: age, sex, educa-
tion, duration of lithium treatment since the first test-
ing, lifetime duration of lithium treatment, serum 
lithium level on the morning of the day of testing, sub-
jective awareness of memory impairment (measured on 
a visual analogue scale), other current medication, the 
number of major manic and/or depressed episodes since 
the first testing, and the number of hospitalizations 
since the first testing {both obtained from the patient's 
clinical records). 
Procedure 
When the patients arrived, the examiner described 
the nature and objectives of the study, outlined the pro-
cedures involved, and obtained their informed written 
consent to participate. Serum lithium levels were mea-
sured in the morning on the day of testing after a brief 
clinical examination. The Zung SDS was completed by 
the patient, followed by the administration of the SIS, 
BVRT, and WMS. Patients were reimbursed for their 




Although both the WMS and the BVRT have been 
shown to have relatively high test-retest reliability, we 
computed the interrater reliability for the BVRT since 
the records for the two testing occasions were scored by 
different individuals. One of us (J.K.l rescored the 
BVRT records from the first testing of 10 randomly se-
lected patients and computed the Pearson product mo-
ment correlation coefficient between his results and 
those obtained by the first examiner. The correlation co-
efficients for the Correct Cards and Error Design scores 
were 0.94 and 0.97, respectively, indicating a very high 
degree of interrater reliability. 
Sample description 
Table 1 contains relevant demographic and clinical 
variables for the sample of18 patients at the second test-
TABLE 1. Demographic and clinical variables for the 18 s ubjects at the 
second testing 
Variables Mean SD 
Age 45.8 13.7 
Education 13.8 3.2 
Subjective sense of memory impairment 22.9 17.5 
<0-100> 
Serum lithium lmEqiliterl 0.61 0.27 
Months of lithium in lifetime 108.9 63.5 
Months of lithium between testings 66.0 15.9 
No. ofmaniddepressed episodes between 0.67 0.77 
testings 
No. of hospitalizations between testings 0.22 0.43 
ing. It is evident that as a group this sample has been 
relatively healthy since the first testing as indicated by 
the small mean number of major episodes (0.67) and 
hospitalizations (0.22). Although retesting was done ap-
proximately 6 years later, the average duration of lith-
ium treatment for this interval was 5.5 years, indicating 
that not all patients had been maintained on continuous 
lithium therapy. 
Serum lithium levels were within therapeutic limits 
for all subjects at both testings, ranging from 0.60 to 1.2 
mEq/liter at the first testing and from 0.26 to 1.1 mEq/ 
liter at the second. All patients were clinically evalu-
ated prior to testing. There were no symptoms of lith-
ium toxicity or any abnormal serum lithium levels to 
suggest toxicity. 
Memory functions ouer time 
Table 2 shows the means and standard deviations for 
the BVRT, WMS, and the Zung SDS Index at the two 
testings for the sample ofl8 subjects. These data show a 
remarkable stability over time: the mean WMS mem-
ory quotients for the first and second testings were 112.4 
and 112.8, respectively. A statistical comparison of the 
change in performance over the 6-year interval was 
computed for each memory score shown in Table 2 by a 
TABLE 2. A comparison of the mean memory test scores and the Zung 
SDS Index at the two testings 
First testing: Second testin~-:: 
meaniSDI mean !SOl 
BVRT 
No. correct cards score 6.812.3! K51.1.91 
Error design score 5.114.91 4.9<3.71 
WMS 
Information 5.810.5! 5.010.01 
Orientation 4.910.21 4.910.21 
Mental control 7.411.91 7.311.91 
Logical memory 9.312.91 9.613.91 
Digit span 11.712.31 10.611.81 
Visual reproduction 10.213.61 9.513.91 
Associate learning 15.413.61 16.113.11 
Memory quotient 112.4117.11 J 12.8117.81 
Zung SDS Index 39.419.1) 37.917.91 
univariate one-way repeated measurement ANOVA. 
The only variable that showed a significant decrease 
over the testings was the information subtest of the 
WMS (F(l,l7l = 47.20, p < 0.0001: At the second test-
ing, all subjects failed on the WMS information subtest 
item, which requests the name of the former Prime 
Minister of Canada: and instead, all named his pre-
decessor. Lack of variation in responses for this sub test 
is seen in a standard deviation of zero in Table 2. The 
statistically significant difference observed between 
testings on the information subtest is best interpreted 
as an artifact of recent public events in Canada; the clin-
ical significance of this difference is negligible. It is 
important to note that there were no significant differ-
ences between testings on any other variable measur-
ing memory functioning. 
To further assess the effects of long-term lithium 
therapy on memory functioning the sample was split, at 
the median, into two groups of equal size based on the 
patients' lifetime duration of lithium therapy (median, 
7.6 years of lithium treatment). This resulted in a "long-
term" group with a mean duration of 12.9 years of lith-
ium therapy and a "shorter-term" group with a mean of 
5.2 years. Mean memory test scores from the second 
testing were compared by a series of univariate one-way 
ANCOVAs using age and the first testing memory 
scores as covariates. There were no significant dif-
ferences between the two groups on any of the 10 mem-
ory measures. 
Table 3 contains the significant I p < 0.05) correla-
tions found between the clinical variables obtained 
from the SIS, the memory test scores, and the Zung SDS 
Index. For ease of reading in the table, all nonsignifi-
cant correlations have been omitted and replaced by 
empty cells. Correlations involving the information and 
orientation subtests and the number of hospitalizations 
and manic or depressed episodes between testings were 
not computed given the extremely small range of ob-
served values for these variables. 
Several findings in Table 3 are noteworthy. First, 
there is a negative relationship between five memory 
test scores and the duration of lithium therapy (as mea-
sured by the total lifetime duration as well as the dura-
tion between testings). These findings indicate that, in 
general, the longer a patient received lithium, the 
poorer was his or her memory test performance on the 
BVRT error design score, three WMS subtests, and the 
WMS memory quotient. However, three of these mem-
ory scores were also positively correlated with the pa-
tients' ages. Thus, age may account in part for the rela-
tionship between the duration of lithium treatment and 
memory performance. 
Second, the patients' subjective sense of memory im-
pairment correlated with the Zung SDS Index (r = 0.521 
as well as with age (r = 0.62). In addition, subjective 
sense of memory impairment was significantly corre-
lated with three of the objective memory test scores 
measuring immediate and short-term visual reproduc-
tion but not with duration of lithium therapy. None of 
the 10 memory subtests correlated significantly with 
scores on the Zung SDS Index. 
Finally, performance on the digit span subtest corre-
lated positively with both the lifetime duration of lith-
ium therapy (r = 0.40) and serum lithium level just 
prior to testing (r = 0.72). 
Comment and Conclusions 
The results of the present study supported the hy-
pothesis of no difference in memory test performance 
TABLE 3. Correlations of the memory test results with the clinical and demographic variables at the second testing" 
Serum Lifetime Lithium Subjective 
Variables Age Education lithium lithium between memory 
<mEq/literl <months! testings impairment 
<months I 
BVRT 
Correct cards - 0.47 0.54 - 0.52 




Mental control - 0.42 
Logical memory -0.50 - 0.62 - 0.45 
Digit span 0.72 0.40 
Visual reproduction 0.67 0.40 
Associate learning -0.40 0.46 - 0.61 - 0.49 
Memory quotient 0.40 - 0.56 
Subjective memory impairment 0.62 -0.40 
Zung SDS Index 0.52 
Age 0.43 0.62 
•All correlation coefficients are significant at the 5'/f level or less. 
over time, demonstrating that after a mean duration of 
5.5 years of lithium treatment spanning a 6-year inter-
val between testings, memory functions remained re-
markably stable and unchanged. With the exception of 
the poorer performance on the information subtest of 
the WMS at the second testing, there were no signifi-
cant changes in any of the remaining nine memory test 
scores. Furthermore, comparisons of the long-term and 
shorter term lithium therapy groups (with means of 
12.9 and 5.2 years of lithium treatment, respectively) 
yielded no significant memory score differences. 
Clearly, these findings do not support the claim that 
long-term lithium therapy results in impaired memory 
performance. 
Despite these unequivocal findings, the negative cor-
relations between several of the memory test scores and 
the duration of lithium treatment would seem to indi-
cate that long-term lithium use is associated with 
poorer memory performance. However, these correla-
tions should be interpreted cautiously since both the 
lifetime duration of lithium treatment and four of the 
memory test scores were also significantly related to 
the patients' ages. Thus, it seems reasonable to conclude 
that the association between memory performance and 
lithium duration can, in part, be accounted for by the 
patients' ages. 
Our second hypothesis was only partially confirmed. 
As predicted, the patients' ratings of their subjective 
sense of memory impairment correlated with scores on 
the Zung SDS Index (as well as with age). The most 
likely explanation of these findings is that the combined 
effects of age and level of depression are in part respon-
sible for the subjective sense of impaired memory func-
tioning that these patients report. However, contrary to 
our expectation, these subjective ratings were also asso-
ciated with poorer performance on three memory tasks 
involving focused attention and visual-motor coordina-
tion in reproducing designs. Taken together, these re-
sults indicate that when patients with bipolar disorder 
report a sense of impaired memory functioning, their 
reports may accurately reflect their performance on ob-
jective memory tests. Whereas age and level of depres-
sion may contribute to a sense of impaired memory 
functioning, and age to lowered performance on objec-
tive tests of memory, there is no evidence that this is the 
case for duration of lithium treatment. 
The finding that serum lithium levels were highly 
correlated with performance on the digit span subtest 
indicated that higher lithium levels were associated 
with better performance on this subtest. In addition to 
being a test of immediate memory, the digit span sub-
test requires focused attention and concentration for 
successful performance. Factor-analytic studies reveal 
that the digit span subtest loads most highly on factors 
that measure "freedom from distractibility. "lri Thus, pa-
tients with higher serum lithium levels may have bene-
fited from the stabilizing effects of lithium and per-
formed better with fewer internal or external distractions. 
Results from the original study9 showed that at the 
first testing digit span test scores correlated signifi-
cantly with duration of lithium therapy (r = 0.42). At 
that time patients had been receiving lithium treat-
ment for an average of approximately 2 years. The pres-
ent study demonstrated at follow-up, after an additional 
5.5 years of lithium treatment, that these variables 
were still significantly correlated. This finding provides 
further evidence of the stability of memory functions 
over time despite the intervening years of lithium 
treatment. 
Finally, it is evident from the demographic and clini-
cal variables presented in Tables 1 and 2 that the pres-
ent sample was overrepresented by males, who were rel-
atively well educated, showed an above average WMS 
memory quotient, and did not demonstrate much psy-
chopathology over the 6-year interval between testings. 
This latter finding, however, is probably evidence of the 
prophylactic effect of lithium. Further long-term eval-
uations of the effects of lithium treatment on memory 
functioning in larger samples of patients with bipolar 
affective disorder are warranted. 
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